Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma

Annals of Surgery

Volumn 244, Issue 2, 2006, Pages 296-304

  Monchik, Jack M ^a   Donatini, Gianluca ^a   Iannuccilli, Jason ^a   Dupuy, Damian E ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; THYROGLOBULIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BURN; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MALE; NECK CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR BIOPSY; ULTRASOUND; VOCAL CORD PARALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARCINOMA, PAPILLARY; CATHETER ABLATION; DISEASE-FREE SURVIVAL; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOGRAPHY, INTERVENTIONAL; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THYROGLOBULIN; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL; WHOLE BODY IMAGING;

EID: 33748120000     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000217685.85467.2d     Document Type: Article

References (35)

1. Landis SH, Murray T, Bolden S, et al. Cancer Statistics, 1999. CA Cancer J Clin. 1999;48:8.
2. Cotran RS, Kumar V, Collins T. Robbins: Pathologic Basis of Disease. Philadelphia: Saunders, 1999:1142.
3. Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991. Cancer. 1997;79:564-572.
4. Dupuy DE, Monchik JM. Radiofrequency ablation of recurrent thyroid cancer. In: Ellis, Curley, Tanabe, eds. Textbook Radiofrequency Ablation of Cancer. New York: Springer-Verlag, 2003:213-223.
5. Loh K, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997;82:3553-3561.
6. Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg. 1994;18:552-558.
7. Schlumberger M, Tubiana M, de Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986;63:960-967.
8. Foneseca P. Thyroid lung metastasis diagnosed 47 years after thyroidectomy. Ann Thorac Surg. 1999;67:856-857.
9. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720.
10. Casara D, Rubello D, Saladini G, et al. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori. 1991;77:432-436.
11. Bernier M, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2001;86:1568-1573.
12. Ruegemer JJ, Bergstalh EJ, Ryan JJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988;67:501-508.
13. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and longterm outcome in 2444 consecutively treated patients. World J Surg. 2002;8:879-885.
14. Lencioni R, Cioni D, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma. State of the Art Liver Transpl. 2004;10(suppl):91-97.
15. Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:371-977.
16. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radio-frequency energy. Radiology. 2000;217:633-646.
17. Dupuy DE, Hong R, Oliver B, et al. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol. 2000;175:1263-1266.
18. Rosenthal DI, Hornicek FJ, Wolfe MW, et al. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998;83:4195-4203.
19. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57-59.
20. Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology. 2000;217:665-672.
21. Dupuy DE, Mayo-Smith WW, Cronan JJ. Image-guided biopsy and radiofrequency ablation of renal masses. Semin Interv Radiol. 2000;17:373-379.
22. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities. Parts I and II. J Vasc Interv Radiol. 2001;12:1021-1032, 1135-1148.
23. Pacini F. Role of percutaneous ethanol injection in management of nodular lesions of the thyroid gland. J Nuc Med. 2003;44:211-212.
24. Charboneau JW, Hay ID, van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc. 1988;63:913-917.
25. Lewis BD, Hay ID, Charboneau JW, et al. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol. 2002;178:699-704.
26. Braga-Basaria M, Ringel M. Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer. J Clin Endocrinol Metab. 2003;88:1947-1960.
27. Solbiati L, Ierace T, Dellanoce M, et al. Percutaneous US-guided radiofrequency ablation of metastatic lymph nodes from papillary cancer of the thyroid gland: initial experience in two cases. Radiology. 1998;209:385.
28. Proye CA, Dromer DH, Carnaille BM, et al. Is it still worthwhile to treat bone metastasis from differentiated thyroid carcinoma with radioactive iodine? World J Surg. 1992;16:640-646.
29. Petrich T, Widjaia A, Musholt TJ, et al. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side effects and influence of age. Eur J Nucl Med Mol Imaging. 2001;28:203-208.
30. Payne R, Janjan NA. Management of metastatic bone pain. In: Payne R, Patt RB, Hill CS, eds. Assessment and Treatment of Cancer Pain, vol. 12. Seattle: IASP, 1998:269-273.
31. Livraghi T, Solbiati L. Complication after cool-tip RF ablation of liver cancer: initial report of the Italian Multicenter Cool-tip RF study group. Radiology. 2000;217:18.
32. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radiofrequency ablation. Radiology. 2002;224:97.
33. Jain SK, Dupuy DE. Radiofrequency ablation for skeletal metastasis of papillary carcinoma of the thyroid: conjunct treatment with radioablative iodine. Endocrinologist. 2004;141:5-11.
34. Sugitani I, Kasai N, Fujimoto Y. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139-148.
35. Maisano R, Pergolizzi S, Cascinu S. Novel therapeutic approaches to cancer patients with bone metastases. Crit Rev Oncol Hematol. 2001;40:239-250.